Director, Renal Denervation (RDN) Health Economics, Policy & Reimbursement Director (HEPR)

We anticipate the application window for this opening will close on - 9 Nov 2026   Careers that change lives start here. Medtronic is a global leader in healthcare technology with a Mission to alleviate pain, restore health, and extend life. Our 95,000 employees work across more than 150 countries to put patients first — developing innovative medical technologies that improve the lives of 72+ million patients each year. Your unique talents will help shape the future of healthcare while building a career grounded in purpose, growth, and impact. A Day in the Life Interventional Cardiology Therapies (ICT) brings together Medtronic’s Structural Heart, Coronary, and Renal Denervation businesses to support interventional cardiologists and heart teams with a connected, patient-focused approach. We offer a comprehensive, integrated portfolio of products aligned around the needs of the interventional cardiology service line, including innovative solutions that support the diagnosis and treatment of coronary artery disease, the restoration of structural heart functions, and the management of hypertension. At Medtronic, we bring bold ideas forward with speed and decisiveness to put patients first in everything we do. This position is remote to enhance our competitive edge and expand our cross-functional collaboration efforts. This role will require 40% of travel to enhance collaboration and ensure successful completion of projects.                     The Renal Denervation (RDN) Health Economics, Policy, and Reimbursement (HEPR) Director leads the development and execution of strategies to achieve payer access, demonstrate therapy value, and expand patient access to Medtronic RDN therapies in the United States and globally. This leadership role drives U.S. and global reimbursement strategy development, business development opportunities, clinical & economic evidence planning, and global commercial product launches for RDN. This position must understand, develop, and communicate the clinical and economic evidence needed to secure public and private payer coverage, coding, and sustainable payment. The role develops business- and therapy-specific reimbursement strategies spanning coding, coverage, and payment/funding, and partners with regional & local market access colleagues to establish, maintain, and protect access in target geographies. This role closely collaborates with HEPR leadership, Corporate HEPR colleagues, and business, regional, and functional leaders to establish and deliver reimbursement priorities and strategies. The Director will have a team of direct reports and will collaborate with numerous other HEPR and functional teams that support RDN reimbursement objectives.  This is a highly visible role that requires an experienced leader adept at executive leadership communications, matrixed organizational design and maneuverability, and global agility. Role and Responsibilities • Leads overall RDN HEPR strategy and initiatives, in alignment with business priorities and budgets.  Responsible for connecting reimbursement and market access plans to business value and growth strategies. • Develops and executes integrated U.S. and global market access strategies, incorporating reimbursement, health economics, evidence generation, coding, coverage, payment, and payer value proposition considerations. • Collaborates closely with the Payer Engagement team to set and communicate priorities and execute comprehensive tactics to expand U.S. payer coverage. • Provides strategic leadership on U.S. Medicare reimbursement pathways, including coverage and payment.  This includes continued strategic leadership related to the Medicare RDN National Coverage Determination (NCD) and existing add-on payments, including New Technology Add-on Pay